164 related articles for article (PubMed ID: 37981958)
1. Cholesterol crystals induce mechanical trauma, inflammation, and neo-vascularization in solid cancers as in atherosclerosis.
Abela GS; Katkoori VR; Pathak DR; Bumpers HL; Leja M; Abideen ZU; Boumegouas M; Perry D; Al-Janadi A; Richard JE; Barnaba C; Meza IGM
Am Heart J Plus; 2023 Nov; 35():. PubMed ID: 37981958
[TBL] [Abstract][Full Text] [Related]
2. Phospholipid nanoparticles: Therapeutic potentials against atherosclerosis via reducing cholesterol crystals and inhibiting inflammation.
Luo Y; Guo Y; Wang H; Yu M; Hong K; Li D; Li R; Wen B; Hu D; Chang L; Zhang J; Yang B; Sun D; Schwendeman AS; Eugene Chen Y
EBioMedicine; 2021 Dec; 74():103725. PubMed ID: 34879325
[TBL] [Abstract][Full Text] [Related]
3. Effect of cholesterol crystals on plaques and intima in arteries of patients with acute coronary and cerebrovascular syndromes.
Abela GS; Aziz K; Vedre A; Pathak DR; Talbott JD; Dejong J
Am J Cardiol; 2009 Apr; 103(7):959-68. PubMed ID: 19327423
[TBL] [Abstract][Full Text] [Related]
4. Viewing atherosclerosis through a crystal lens: How the evolving structure of cholesterol crystals in atherosclerotic plaque alters its stability.
Nidorf SM; Fiolet A; Abela GS
J Clin Lipidol; 2020; 14(5):619-630. PubMed ID: 32792218
[TBL] [Abstract][Full Text] [Related]
5. Interaction between bacteria and cholesterol crystals: Implications for endocarditis and atherosclerosis.
Boumegouas M; Raju M; Gardiner J; Hammer N; Saleh Y; Al-Abcha A; Kalra A; Abela GS
PLoS One; 2022; 17(2):e0263847. PubMed ID: 35180238
[TBL] [Abstract][Full Text] [Related]
6. The effect of colchicine on cholesterol crystal formation, expansion and morphology: a potential mechanism in atherosclerosis.
Abideen ZU; Pathak DR; Sabanci R; Manu M; Abela GS
Front Cardiovasc Med; 2024; 11():1345521. PubMed ID: 38495937
[TBL] [Abstract][Full Text] [Related]
7. Debris collected in-situ from spontaneously ruptured atherosclerotic plaque invariably contains large cholesterol crystals and evidence of activation of innate inflammation: Insights from non-obstructive general angioscopy.
Komatsu S; Yutani C; Takahashi S; Takewa M; Ohara T; Hirayama A; Kodama K
Atherosclerosis; 2022 Jul; 352():96-102. PubMed ID: 35300852
[TBL] [Abstract][Full Text] [Related]
8. Frequency of Cholesterol Crystals in Culprit Coronary Artery Aspirate During Acute Myocardial Infarction and Their Relation to Inflammation and Myocardial Injury.
Abela GS; Kalavakunta JK; Janoudi A; Leffler D; Dhar G; Salehi N; Cohn J; Shah I; Karve M; Kotaru VPK; Gupta V; David S; Narisetty KK; Rich M; Vanderberg A; Pathak DR; Shamoun FE
Am J Cardiol; 2017 Nov; 120(10):1699-1707. PubMed ID: 28867129
[TBL] [Abstract][Full Text] [Related]
9. The relationships between cholesterol crystals, NLRP3 inflammasome, and coronary atherosclerotic plaque vulnerability in acute coronary syndrome: An optical coherence tomography study.
Xue C; Chen Q; Bian L; Yin Z; Xu Z; Zhang H; Zhang Q; Zhang J; Wang C; Du R; Fan L
Front Cardiovasc Med; 2022; 9():905363. PubMed ID: 36386333
[TBL] [Abstract][Full Text] [Related]
10. Cholesterol crystallization in human atherosclerosis is triggered in smooth muscle cells during the transition from fatty streak to fibroatheroma.
Ho-Tin-Noé B; Vo S; Bayles R; Ferrière S; Ladjal H; Toumi S; Deschildre C; Ollivier V; Michel JB
J Pathol; 2017 Apr; 241(5):671-682. PubMed ID: 28039859
[TBL] [Abstract][Full Text] [Related]
11. Cholesterol crystals use complement to increase NLRP3 signaling pathways in coronary and carotid atherosclerosis.
Niyonzima N; Bakke SS; Gregersen I; Holm S; Sandanger Ø; Orrem HL; Sporsheim B; Ryan L; Kong XY; Dahl TB; Skjelland M; Sørensen KK; Rokstad AM; Yndestad A; Latz E; Gullestad L; Andersen GØ; Damås JK; Aukrust P; Mollnes TE; Halvorsen B; Espevik T
EBioMedicine; 2020 Oct; 60():102985. PubMed ID: 32927275
[TBL] [Abstract][Full Text] [Related]
12. Formation and Cellular Impact of Cholesterol Crystals in Health and Disease.
Baumer Y; McCurdy SG; Boisvert WA
Adv Biol (Weinh); 2021 Nov; 5(11):e2100638. PubMed ID: 34590446
[TBL] [Abstract][Full Text] [Related]
13. Cholesterol crystal as a new feature of coronary vulnerable plaques: An optical coherence tomography study.
Nishimura S; Ehara S; Hasegawa T; Matsumoto K; Yoshikawa J; Shimada K
J Cardiol; 2017 Jan; 69(1):253-259. PubMed ID: 27156165
[TBL] [Abstract][Full Text] [Related]
14. Alpha-cyclodextrin inhibits cholesterol crystal-induced complement-mediated inflammation: A potential new compound for treatment of atherosclerosis.
Pilely K; Bakke SS; Palarasah Y; Skjoedt MO; Bartels ED; Espevik T; Garred P
Atherosclerosis; 2019 Apr; 283():35-42. PubMed ID: 30772772
[TBL] [Abstract][Full Text] [Related]
15. Epicardial adipose tissue density and volume are related to subclinical atherosclerosis, inflammation and major adverse cardiac events in asymptomatic subjects.
Goeller M; Achenbach S; Marwan M; Doris MK; Cadet S; Commandeur F; Chen X; Slomka PJ; Gransar H; Cao JJ; Wong ND; Albrecht MH; Rozanski A; Tamarappoo BK; Berman DS; Dey D
J Cardiovasc Comput Tomogr; 2018; 12(1):67-73. PubMed ID: 29233634
[TBL] [Abstract][Full Text] [Related]
16. [Impact of CD137-CD137L signaling mediated exocytosis of autophagosome within vascular smooth muscle cells on the formation of atherosclerotic calcification].
Li B; Li XY; Zhong W; Shao C; Wang ZQ; Yuan W; Yan JC
Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Jan; 45(1):49-56. PubMed ID: 28100346
[No Abstract] [Full Text] [Related]
17. Cholesterol Crystals as the Main Trigger of Interleukin-6 Production through Innate Inflammatory Response in Human Spontaneously Ruptured Aortic Plaques.
Komatsu S; Yutani C; Takahashi S; Takewa M; Iwa N; Ohara T; Kodama K
J Atheroscler Thromb; 2023 Nov; 30(11):1715-1726. PubMed ID: 37081615
[TBL] [Abstract][Full Text] [Related]
18. Anchoring β-CD on simvastatin-loaded rHDL for selective cholesterol crystals dissolution and enhanced anti-inflammatory effects in macrophage/foam cells.
He J; Zhou X; Xu F; He H; Ma S; Liu X; Zhang M; Zhang W; Liu J
Eur J Pharm Biopharm; 2022 May; 174():144-154. PubMed ID: 35447349
[TBL] [Abstract][Full Text] [Related]
19. Cholesterol crystal depth in coronary atherosclerotic plaques: A novel index of plaque vulnerability using optical frequency domain imaging.
Koide M; Matsuo A; Shimoo S; Takamatsu K; Kyodo A; Tsuji Y; Mera K; Tsubakimoto Y; Isodono K; Sakatani T; Inoue K; Fujita H
PLoS One; 2017; 12(6):e0180303. PubMed ID: 28665970
[TBL] [Abstract][Full Text] [Related]
20. Cholesterol crystals in non-culprit plaques of STEMI patients: A 3-vessel OCT study.
Qin Z; Cao M; Xi X; Zhang Y; Wang Z; Zhao S; Tian Y; Xu Q; Yu H; Tian J; Yu B
Int J Cardiol; 2022 Oct; 364():162-168. PubMed ID: 35705168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
